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Sweden
Gap pre-pulse inhibition of the acoustic startle (GPIAS) is a behavioral paradigm used
for inferring the presence of tinnitus in animal models as well as humans. In contrast to
pre-pulse inhibition (PPI), the neural circuitry controlling GPIAS is poorly understood. To
increase our knowledge on GPIAS, a comparative study with PPI was performed in mice
combining these behavioral tests and c-Fos activity mapping in brain areas involved in
the inhibition of the acoustic startle reflex (ASR). Both pre-pulses and gaps efficiently
inhibited the ASR and abolished the induction of c-Fos in the pontine reticular nucleus.
Differential c-Fos activation was found between PPI and GPIAS in the forebrain whereby
PPI activated the lateral globus pallidus and GPIAS activated the primary auditory cortex.
Thus, different neural maps are regulating the inhibition of the startle response by pre-
pulses or gaps. To further investigate this differential response to PPI and GPIAS,
we pharmacologically disrupted PPI and GPIAS with D-amphetamine or Dizocilpine
(MK-801) to target dopamine efflux and to block NMDA receptors, respectively. Both
D-amp and MK-801 efficiently decreased PPI and GPIAS. We administered Baclofen, an
agonist GABAB receptor, but failed to detect any robust rescue of the effects of D-amp
and MK-801 suggesting that PPI and GPIAS are GABAB-independent. These novel
findings demonstrate that the inhibition of the ASR by pre-pulses or gaps is orchestrated
by different neural pathways.
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INTRODUCTION
Pre-pulse inhibition (PPI) is a quantitative measure of the sensorimotor gating where a pre-
pulse attenuates the motor reflex that is induced by a subsequent acoustic startle. The acoustic
startle reflex (ASR) is a primitive survival reaction relying on the dorsal cochlear nucleus
(DCN), the caudal pontine reticular nucleus (PnC), and spinal motor neurons (Koch, 1999).
Higher order nuclei including the limbic system and the prefrontal cortex regulate the inhibition
of the ASR during PPI. It is known that the activation of dopamine and the blockade of
NMDA receptors can disrupt the function of the pre-frontal cortex and the nucleus accumbens
and lead to impaired PPI (Koch and Schnitzler, 1997). Altered PPI responses are found in
a variety of psychiatric disorders including schizophrenia, obsessive–compulsive disorder, and
Tourette’s syndrome (Braff et al., 2001; Swerdlow et al., 2008, 2016). Enhancing GABAergic
Frontiers in Cellular Neuroscience | www.frontiersin.org 1 February 2017 | Volume 11 | Article 19
fncel-11-00019 February 4, 2017 Time: 17:58 # 2
Moreno-Paublete et al. Neural Basis of GPIAS
inhibition has been used as strategy to circumvent the disrupted
dopamine/glutamate circuitry and to restore the inhibitory inputs
to the PnC and PPI (Braff et al., 2001; Swerdlow et al., 2008,
2016).
A variant to PPI is gap pre-pulse inhibition of the
acoustic startle response (GPIAS), which has emerged as
a potential tool for the assessment of tinnitus in animals
and humans (Galazyuk and Hebert, 2015). Conceived by
Turner et al. (2006) and Turner and Parrish (2008) it was
validated against a model of operant conditioning and was
further supported by additional neuronal correlates of tinnitus
including increased spontaneous firing rates (SFRs) in the
DCN (Li et al., 2013, 2015), hyperactivity in the inferior
colliculus (IC) (Holt et al., 2010) and remapping of the
auditory cortex (AC) (Engineer et al., 2011). Unlike PPI,
GPIAS uses a silent gap embedded in a carrier noise as a
pre-stimulus to decrease a subsequent ASR. When the carrier
frequency closely matches that of the tinnitus, it interferes with
the optimal inhibition caused by the silent gap. Lowe and
Walton (2015) adapted the GPIAS to assess neuronal responses
instead of startle responses using a paradigm named auditory
brainstem response gap-in-noise (ABR GIN), which showed
similar efficacy in detecting tinnitus. How GPIAS and PPI,
which are elicited by different auditory cues, differ in terms of
neural mapping and pharmacological regulation, remains to be
determined.
Some of the temporal characteristics and neural circuitry
used to elicit inhibition with gaps or pre-pulses differ. For
instance, PPI is stable within a large range of inter-stimulus
intervals (ISI), whereas GPIAS improves with shorter lead times
in mice depending on the strain (Yu et al., 2016). Moreover,
the AC appears as an important regulator of GPIAS, but
not PPI, as shown by surgical ablation studies (Bowen et al.,
2003). Recent optogenetic studies in mice have shown that
GABAergic interneuron activity in the AC is important in
controlling perceptual gap detection (Weible et al., 2014). With
the exception of the AC, little is known about the neural
structures controlling GPIAS. In this study, we performed
behavioral tests and histological evaluations based on c-Fos




Experimental procedures on animals were performed in
accordance with the guidelines and regulations set out by
Stockholm’s Norra Djurförsöksetiska Nämnd (N156/14). Male
mice from 3 to 4 months of age in a C57BL/6JRj background
(Janvier Labs, France), were group-housed (4–5 per cage) and
maintained at 19–21◦C in a 50–50% light-dark cycle (lights on
at 06:00). Animals had free access water and food (Lactamin
R34, Lantmännen) and were given a minimum of 1 week
acclimatization upon their arrival prior to any manipulation.
All behavioral experiments were carried out between 09:00 and
16:00 h.
Gap-Pre-pulse Inhibition of the Startle
Eesponse (GPIAS) and Pre-pulse
Inhibition (PPI)
A SR-Lab startle response system from San Diego Instruments
was used. A background carrier sound level consisted of an
unfiltered white noise at 65 dB sound pressure level (SPL) for PPI.
Pre-pulses of 3, 6, and 12 dB SPL above the carrier noise were
used. For GPIAS, the gaps were 6, 11 and 16 dB SPL below the
carrier noise, and the lowest level of the gaps was 65 dB SPL (noise
floor). Both pre-pulses and gaps were 50 ms in duration and had
0.1-ms rise and fall times. Startle pulses of 20 ms were presented
at 114 dB SPL. Calibration was performed before each procedure
and SPL were measured with a calibrated microphone and
preamplifier (4939-A-011 and 2633, Brüel & Kjær), connected to
an amplifier (Brüel & Kjær, type 2636). The ISI was set at 70 ms
for pre-pulses and 15 ms for silent gaps according to Yu et al.
(2016). Gap detection or pre-pulse inhibition was quantified as
[(1 – (startle amplitude during pre-pulse or gap + pulse)/(startle
amplitude during pulse alone)) × 100)] (Yu et al., 2016), using
a similar representation as used in pre-pulse inhibition studies
(greater suppression of the startle reflex closer to 100%).
Experimental Procedure for PPI and GPIAS
A 10 min acclimatization to the procedure was conducted on day
1. On the following day (day 2), a baseline experiment comprised
a complete test with both PPI and GPIAS sessions, and the same
scheme was used on day 5 for the evaluation of drug effects. PPI
sessions were performed first, immediately followed by GPIAS
sessions. A pilot test showed that inverting PPI and GPIAS did
not alter the outcome of the study in presence or absence of
drugs. The PPI and GPIAS sessions were initiated after a 5 min
acclimatization to the environment, followed by 5 min in a 65 dB
SPL continuous white noise.
PPI session
The PPI session started with five startle pulses; each pulse was
20 ms in duration and at 114 dB SPL. PPI was tested at a single
carrier intensity (white noise) of 65 dB SPL with trials containing
pre-pulses of 3, 6, and 12 dB SPL above the carrier level. Each pre-
pulse intensity was tested pseudo-randomly 10 times with eight
no stimulus trials randomly inserted. The time between each trial
was random and between 9 and 15 s. The session ended with five
trials containing only startle pulses to be compared with those of
the beginning of the session to assess habituation.
GPIAS session
The GPIAS session started with five startle pulses 20 ms in
duration and at 114 dB SPL. GPIAS was then tested at a different
carrier intensities (white noise) with trials containing gaps of
6, 11, and 16 dB SPL below the carrier level and reaching a
floor of 65 dB SPL. Each intensity was tested pseudo-randomly
10 times with eight no stimulus trials randomly inserted. The
session ended with five trials containing only startle pulses to be
compared with those of the beginning to assess habituation.
A total of 118 trials were presented in approximately 40 min.
A schematic diagram illustrating the sequence of the sessions
performed on day 5 is presented in Figure 1A. The sequence
Frontiers in Cellular Neuroscience | www.frontiersin.org 2 February 2017 | Volume 11 | Article 19
fncel-11-00019 February 4, 2017 Time: 17:58 # 3
Moreno-Paublete et al. Neural Basis of GPIAS
FIGURE 1 | Impairment of pre-pulse inhibition and gap pre-pulse inhibition of the acoustic startle by D-amp and MK-801. (A) Schematic diagram of the
behavioral tests performed to evaluate the effects of drugs on pre-pulse inhibition (PPI) and gap pre-pulse inhibition of the acoustic startle (GPIAS). Effect of acute
D-amp (10 mg/kg, gray) and MK-801 (0.5 mg/kg, dark) administration on PPI (B) and GPIAS (C). Data represent mean ± SEM (n = 13–19). ∗P < 0.05, ∗∗P < 0.01,
∗∗∗P < 0.0001.
of PPI and GPIAS trials for these sessions are provided in the
supplementary method (Supplementary Data Sheet 1).
PPI and GPIAS Sessions for c-FOS Evaluation in the
Brain
For the evaluation of c-Fos induction in the brain, mice were
acclimatized to the procedure 10 min per day, for 3 consecutive
days. On day 4, mice were randomly allocated to six test groups,
which lasted approximately 20 min. Each session started with a
10 min acclimatization (5 min silence and 5 min background
noise) followed by one session of 60 trials with a random inter-
trial time interval from 10 to 20 s. The six sessions were as follows:
(i) carrier noise only (65 dB SPL), (ii) startle only (60 startle
pulses), (iii) pre-pulses (60 pre-pulses), (iv) PPI (60 pre-pulses
followed by startle pulses), (v) gaps (60 gaps), and (vi) GPIAS
groups (60 gaps followed by startle pulses). Pre-pulses used here
were +12 dB SPL above carrier noise (65 dB SPL), gaps were
−16 dB SPL below carrier noise (81 dB SPL), startle pulses were
20 ms in duration and 114 dB SPL. A schematic of the trials
presented for the evaluation of c-Fos is shown in Figure 2A.
The sequence of PPI and GPIAS trials used for the evaluation
of c-Fos induction are provided in the supplementary method
(Supplementary Data Sheet 2).
Immunohistochemistry
Animals were anesthetized 2 h after the end of the behavioral
procedure with a mixture of ketamine/xylazine (100/10 mg/kg)
and underwent transcardiac perfusion with phosphate-buffered
saline (PBS) and then with 4% paraformaldehyde. A pilot study
found a 2 h time point to be the most effective in revealing
c-Fos induction when compared to 1 or 3 h after the end
of the experimental procedure. Brains were post-fixed (1 h)
and then cryoprotected in 30% sucrose in PBS, mounted in
NEG 50 (#6502, Thermo Scientific) and frozen prior to serial
sectioning at 14 µm thickness. Sections from four animals
per conditions were immunostained with rabbit-antibodies to
c-Fos (#4384; 1:250; Cell Signaling technology) then incubated
with biotinylated goat anti-rabbit antibodies (BA-1000; Vector
Laboratories, Burlingame, CA, USA) and the avidin/biotin
system (SP-2001; Vector Laboratories, Burlingame, CA, USA)
and visualized using 3, 3′-diaminobenzidine (DAB) solution (SK-
4100; Vector Laboratories). Negative controls were performed
by omitting the primary antibody yielding no staining. Images
were obtained using DP Controller software (Olympus, Tokyo,
Japan) and immunopositive nuclei were counted automatically
using Image-Pro Plus 6.2 software (Media Cybernetics, Rockville,
MD, USA). Pilot studies were performed using counterstaining
with hematoxylin QS (H-3404, Vector Laboratories) to confirm
the different brain regions.
Quantitative Analysis of c-Fos
Immunohistochemistry
Serial coronal sections were examined at 10× magnification
using a Zeiss Axioskop (Zeiss, Germany). Photographs were
Frontiers in Cellular Neuroscience | www.frontiersin.org 3 February 2017 | Volume 11 | Article 19
fncel-11-00019 February 4, 2017 Time: 17:58 # 4
Moreno-Paublete et al. Neural Basis of GPIAS
FIGURE 2 | Lack of c-Fos induction in the PnC upon inhibition by pre-pulses or gaps. Schematic diagram of the behavioral tests performed to evaluate
c-Fos induction in the brain under (A) only carrier noise (control), (B) pulses only (startle), (C) pre-pulses only (pre-pulse), (D) pre-pulses in presence of startle stimuli
(PPI), (E) gaps only (gap), and (F) gaps in presence of startle stimuli (GPIAS). Sections were taken from the PnC (G), which is located caudally from the bregma along
the rostrocaudal axis between −4.96 and −5.68 mm. (H) Representative photomicrographs of c-Fos-immunostaining in the PnC under the six conditions described
in (A–F) Scale bar, 50 µm. Quantification of c-Fos positive cells (I) and big neurons (J) in the PnC of the six groups. Groups with startle pulses are in hatched bars.
Those with pre-pulses are in blue and those with gaps are in red. Data represent means ± SEM (n = 4). ∗∗P < 0.01, ∗∗∗P < 0.0001.
taken with an Olympus DP71 digital camera (resolution of
4140 pixels × 3086 pixels). Franklin and Paxinos (2008)
stereotaxic coordinates were used to define specific brain regions:
(i) the caudal pontine reticular nucleus (PnC), between −4.96
and −5.70 mm; (ii) the lateral globus pallidus (LGP), −0.10
and −1.06 mm; and the auditory cortex (AC), in the region
between −2.18 and −3.64 mm. Both right and left hemispheres
of three different sections separated by at least 140 µm for
each area were examined. Within each section 3 regions of
interest (ROI) were analyzed. The size of the three ROI was
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200 × 200 µm. Using Image-pro 6.2.1 (Media Cybernetics) and
ImageJ 1.50i (NIH), cells with threshold above background were
counted. The researcher performing the analysis was blind to the
experimental conditions. This procedure resulted in a total of 18
determinations of the number of cells stained with c-Fos within a
specified area for each brain.
Pharmacological Procedures
For the pharmacological evaluation of drugs on PPI and GPIAS,
animals were acclimatized to the procedure on day 1, baseline
levels were tested on day 2 and drug treatment effects were
tested on day 5. Mice were injected subcutaneously (s.c.) with
7.5 mg/kg (±) baclofen (B5399; Sigma–Aldrich), followed 15 min
after with 10 mg/kg D-amphetamine hemisulfate salt (A5880,
Sigma–Aldrich) or 0.5 mg/kg MK-801 (M107; Sigma–Aldrich).
For the use of MK-801, we initially tested a 1 mg/kg dose as
previously reported in the literature (Arai et al., 2008), however,
mice appeared lethargic and therefore used a 0.5 mg/kg dose,
which was tolerated better (qualitative observations). Drugs were
dissolved in physiological saline and administered at a volume of
0.2 ml/30 g body weight. The PPI/GAP test was performed 30
or 15 min after the last administration of D-Amp or MK-801,
respectively (Figure 1A). Saline was used as vehicle and control
treatment.
Statistical Analyses
One-way ANOVA and a Tukey post hoc test were used for
all histological quantifications, and a two-way ANOVA and a
Bonferroni post hoc test were used in the context of GPIAS and
PPI (Prism version 4.0, GraphPad software). Differences were
considered significant if p < 0.05. Animals that failed to respond
to the startle (any peak-to-peak response above noise floor) or
failed to inhibit the startle in the presence of a pre-pulse before
treatment (any decrease in startle amplitude during pre-pulse
trials versus startle only trials) were excluded from the analysis
(near 5%).
RESULTS
Disruption of PPI and GAP by D-Amp and
MK-801
The paradigm used for the drug treatment is illustrated
(Figure 1A) and shows the sequence of drug administration
and behavioral tests. PPI increased up to 75% suppression of
the startle response in presence of a +12 dB pre-pulse, whereas
GPIAS achieved near 72% suppression with a −16 dB gap.
These results are illustrating that the paradigm between the two
tests is relatively equal, and a progressive increase in inhibition
with increasing pre-pulse or carrier levels was achieved. D-amp
suppressed PPI by 23–36% in the +6 and +12 dB SPL
pre-pulse intensities [Treatment Factor, F(1,102) = 36.35,
p < 0.0001; Carrier Intensity Factor, F(2,102) = 30.83,
p < 0.0001; Figure 1B]. Similarly, D-amp suppressed GPIAS
by 49–54% in the −11 and −16 dB SPL gaps [Treatment
Factor, F(1,96) = 54.54, p < 0.0001; Carrier Intensity Factor,
F(2,96) = 25.43, p < 0.0001; Figure 1C]. MK-801 suppressed
PPI by 53% in the +6 and +12 dB SPL pre-pulse intensities
[Treatment Factor, F(1,87)= 75.95, p< 0.0001; Carrier Intensity
Factor, F(2,87) = 38.75, p < 0.0001; Figure 1B]. Similarly, MK-
801 suppressed GPIAS by 41–50% in the −11 and −16 dB SPL
gaps [Treatment Factor, F(1,96) = 54.54, p < 0.0001; Carrier
Intensity Factor, F(2,96) = 25.43, p < 0.0001; Figure 1C]. These
findings show that −16 dB SPL gaps inhibit the startle response
to a level equivalent to a +12 dB SPL pre-pulses, and that both
PPI and GPIAS are disrupted by the rise in available dopamine
and NMDA receptor antagonism. Moreover, the data suggest
that GPIAS is more vulnerable to D-Amp than PPI and this was
confirmed by measuring the change caused by D-Amp versus the
individual’s baseline values [q(180) = 4.453, p = 0.0103, data not
shown].
PPI and GPIAS Elicit Similar c-FOS
Responses in the PnC
To identify the differential neural circuits underlying PPI
and GPIAS, we evaluated c-Fos induction in the brain
by immunohistochemistry from mice under the following
conditions: (i) control (carrier noise only), (ii) startle only,
(iii) pre-pulses only, (iv) PPI (pre-pulses in presence of startle
stimuli), (v) gaps only, and (vi) GPIAS (gaps in presence of startle
stimuli) (Figures 2A–F). We hypothesized that regions that
specifically regulating PPI and GPIAS would show a differential
induction of c-Fos. When first assessing the PnC (Figures 2G,H),
the difference across the six groups was significant [Stimulus
Factor, F(5,18)= 10.95, p< 0.0001]. We found that startle pulses
increased by 1.7-fold in the number of c-Fos positive cells in
comparison to the control group [t(18) = 5.382, p = 0.0006,
n = 4 per group; Figure 2I]. Inhibition of the startle by the
optimal gaps (−16 dB SPL) and optimal pre-pulses (+12 dB SPL)
caused a significant decrease of c-Fos induction, down to control
levels [in comparison to startle pulses only – PPI: t(18) = 6.338,
p < 0.0001; GPIAS: t(18) = 3.399, p = 0.0479; n = 4 per group].
The c-Fos expression of the giant nuclei in the PnC was triggered
after the startle stimulus while pre-pulses or gaps did not alter
their activation, suggesting that they are not involved in the
motor output, but instead only responsive to the startle pulse
[in comparison to startle pulses only with an average of six cells
per ROI – PPI: t(18) = 1.705, p > 0.99; GPIAS: t(18) = 1.418,
p> 0.99; n= 4 per group, Figure 2J]. These findings indicate that
the induction of c-Fos in the PnC by startle stimuli is effectively
prevented by both pre-pulses and gaps.
Lack of c-FOS Induction in the LGP after
GPIAS
We next investigated the induction of c-Fos in the LGP
(Figure 3A), known to be involved in the inhibitory pathway
of pre-pulse inhibition (Takahashi et al., 2007). In the LGP, the
difference across the six groups was significant [Stimulus Factor,
F(5,18) = 35.44, p < 0.0001]. We found that both pre-pulses
and PPI increased the number of c-Fos positive cells in the
LGP by near twofold in comparison to startle-only groups [pre-
pulses: t(18) = 9.986, PPI: t(18) = 6.624, p < 0.0001, n = 4 per
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FIGURE 3 | Induction of c-Fos in the LGP by pre-pulses but not gaps. Sections were taken from the LGP (A), which is located caudally from the bregma along
the rostrocaudal axis between −0.10 and −1.06 µm. (B) Representative photomicrographs of c-Fos-immunostaining in the LGP under the six conditions listed in
Figure 2A. Scale bar, 50 µm. (C) Quantification of c-Fos positive cells in the LGP in the six groups. Groups with startle pulses are in hatched bars. Those with
pre-pulses are in blue and those with gaps are in red. Data represent means ± SEM (n = 4). ∗∗∗P < 0.0001.
group; Figures 3B,C]. In contrast, gaps or GPIAS did not trigger
any additional c-Fos staining when compared to the control or
startle-only groups [GAP16: t(18) = 1.623, p > 0.99; GPIAS:
t(18)= 1.171, p> 0.99; n= 4 per group]. These findings strongly
suggest that the LGP is not involved in the inhibitory effects
caused by gaps on startle suppression.
GPIAS Triggers c-Fos Expression in the
AC unlike PPI
Based on studies that have shown the important contribution
of the AC in gap detection (Ison et al., 1991; Bowen et al.,
2003; Weible et al., 2014), we evaluated the changes in c-Fos
positive cells in the primary AC under the six conditions and
the difference across the six groups was significant [Stimulus
Factor, F(5,18) = 5.253, p = 0.0038; Figure 4A]. With the
exception of GPIAS, none of the other conditions triggered
c-Fos staining [GPIAS: t(18) = 3.864, p = 0.0171, n = 4
per group; Figures 4B,C]. Varying the carrier sound intensities
of the control session (e.g., 77, 81 or 100 dB SPL) had
no effect on c-Fos activation in the primary AC (data not
shown). These results indicate that only the inhibition of the
startle pulse by gaps triggers c-Fos induction in the primary
AC.
Baclofen Does Not Rescue from D-amp
or MK-801 Disruption of PPI and GPIAS
In an attempt to restore the disruption of PPI and GPIAS
caused by D-amp and MK-801, we pre-administered baclofen,
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FIGURE 4 | Induction of c-Fos in the Auditory Cortex by GPIAS only. Sections were taken from the primary auditory cortex (AC) (A), which is located caudally
from the bregma along the rostrocaudal axis between −2.18 and −3.64 mm. (B) Representative photomicrographs of c-Fos-immunostaining in the primary AC
under the six conditions listed in Figure 2A. Scale bar, 50 µm. (C) Quantification of c-Fos positive cells in the LGP in the six groups. Groups with startle pulses are
in hatched bars. Those with pre-pulses are in blue and those with gaps are in red. Data represent means ± SEM (n = 4). ∗P < 0.05.
a GABAB receptor agonist that has been previously shown
to block the effects of methamphetamine on PPI (Arai et al.,
2008). Since both D-Amp and MK-801 appeared as effective
disruptors of PPI and GPIAS (Figures 1B,C), we sought to
determine whether pharmacological treatment could restore
normal PPI and GPIAS. We pre-treated animals with baclofen
15 min prior the administration of D-Amp or MK-801 and
performed serial PPI and GPIAS sessions. To exclude the
potential influence of differences in startle responses, we
performed an exclusion based on a criteria previously described
by Stadlbauer et al. (2013). Here, both saline or baclofen
groups served as controls. Animals from any of the drug-
administered groups for which a startle amplitude was lower
than the startle response from control groups were excluded.
Animals from the control group for which a startle amplitude
was higher than any drug-administered group were excluded
as well (Figures 5A,B). Analysis of the average pre-pulses
and gaps of the greatest differences against the carrier noise
(+6 and +12 db SPL in PPI and −11 and −16 dB SPL
in GPIAS) stimuli allowed to summarize the differences as a
whole and establish that baclofen had no effect on D-amp-
or MK-801-induced PPI and GPIAS disruption [PPI MK80-
1: t(172) = 1.329, p > 0.9999; PPI D-Amp: t(172) = 1.150,
p > 0.9999; GPIAS MK80-1: t(172) = 2.350, p = 0.2986; GPIAS
D-Amp: t(172) = 1.852, p = 0.9854; n = 10–18 per group;
Figures 5C,D].
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FIGURE 5 | Lack of rescuing effects of baclofen on PPI and GPIAS. Startle amplitude during PPI (A) and GPIAS (B) sessions under different drug conditions.
The dots represent each individual’s average startle response during pulse-alone trials for each drug-treatment condition. The dotted red line determines the higher
amplitude limit (targeted by the greatest startle amplitude in the drug-administered groups) and/or the lower amplitude limit (targeted by the lowest startle amplitude
in the control group). Red circles indicate the excluded animals. Average PPI (C) and GPIAS (D) scores of the two highest pre-pulse (+6 and +12 dB SPL) and gap
(−11 and −16 dB SPL) stimuli. Data represent means ± SEM (n = 10–19). ∗∗P < 0.01, ∗∗∗P < 0.0001. (E) Schematic of the neuronal pathways involved in PPI and
GPIAS. The acoustic startle reflex (arrows in black) is composed of three neurons: a neuron in the PnC that transfers acoustic stimulus from the cochlear nucleus to
a muscular reaction. Pre-pulses (blue arrows) or gaps (red arrows) are relayed from the cochlear nuclei to the inferior colliculus (IC). In the forebrain, pre-pulses will be
directed to the LGP whereas gaps are directed to the AC. Both pre-pulse and gaps will modulate the pedunculopontine nucleus (PPTg), which will inhibit the PnC.
DISCUSSION
The salient features of this study reveal that the processing of
information during a GPIAS test involves the AC but not the
LGP. This indicates that distinct neural nuclei are recruited
during GPIAS or PPI to inhibit the ASR. It is interesting to note
that a gap within a carrier noise (decreasing intensity) triggers
a similar inhibitory response as a pre-pulse (increased intensity)
but the two paradigms rely on two different brain regions. This
study establishes a framework to better understand the networks
involved in GPIAS and therefore improve the understanding
of its applicability to temporal processing disorders as well as
auditory processing disorders and tinnitus.
We have used c-Fos mapping to compare brain regions
involved in GPIAS and PPI. This method has been successfully
applied to identify regions involved in PPI (Takahashi et al.,
2007; Arai et al., 2008). We found that, in contrast to pre-
pulses, gaps embedded in a carrier background do not elicit
c-Fos activity in the LGP. This is giving a clear neuroanatomical
distinction between these two behavioral paradigms and could
help better understand the regulation of temporal information
encoded by sounds. Corroborating our findings, it has been
found that the LGP is involved in PPI (Takahashi et al., 2007).
Electrolytic ablations or local inactivation of the LGP by lidocaine
have shown to affect the response to pre-pulses (Takahashi
et al., 2007). The involvement of GABAB receptors in the
control of PPI has been suggested with the local injection of
phaclofen (a GABAB receptors antagonist) in the PPTg. Since
GABAergic neurons from the LGP project directly to the PPTg
to control the startle response (Takahashi et al., 2007), it has
been hypothesized that the LGP controls PPTg function through
GABAergic modulation. In contrast to our expectations, baclofen
administration, which enhances GABAergic function via GABAB
receptors, was not able to restore D-amp- or MK-801-induced
PPI or GPIAS disruption. Even though we tested a range of
doses (2.5, 5, 7.5, and 10 mg/kg), none were successful in
rescuing the phenotype (data not shown). The effects of baclofen
are complicated because different studies have shown mixed
results in the rescue of PPI (Bortolato et al., 2004; Arai et al.,
2008; Frau et al., 2014). This could be due to several reasons
including the species or strain used, the analog of amphetamine
(e.g., methamphetamine or D-amphetamine), and the dose. For
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instance, rats have been shown to be responsive to the rescuing
effects of baclofen on MK-801-mediated PPI disruption unlike
C57BL/6J mice. Nonetheless, our findings suggest that PPI and
GPIAS are GABAB-independent in the C57 strain.
We found that GPIAS triggered c-Fos activation in the AC.
Pioneering work from Ison et al. (1991) has demonstrated in rats
the involvement of the AC in GPIAS but not in PPI (Bowen
et al., 2003). Temporary and reversible inhibition of cortical
activity via the application of high concentrations of potassium
chloride (which does not affect the startle response amplitude)
disrupted GPIAS but not PPI (Ison et al., 1991). However, when
the end of the gap signal is coupled to the onset of the startle
stimulus, Ison et al. (1991) were able to reveal that the noise
offset itself does not require cortical control. Lesioning of the AC
yielded similar conclusions (Bowen et al., 2003). It is possible that
gaps presented at different lead times recruit different operating
mechanisms. For instance, in rats gap detection at distal lead
times (>40 ms) requires muscarinic receptor function, which
is not the case at shorter lead times (Ison and Bowen, 2000).
Whether this also applies to mice is unknown. Previous work
from Ison et al. (1991) identified in rats a biphasic response
on startle suppression depending on the interstimulus interval,
which is something we did not observe in mice (Yu et al., 2016).
In the present study, we used short gaps of 20 ms, presented at
15 ms lead times and showed these could trigger c-Fos staining
in the AC in presence of startle stimuli. It is thus possible that the
recruitment of cortical function differs between species. Another
possibility is that pre-pulse inhibition of the startle reflex could
have been sensed by the AC if shorter lead times would have
been used. This possibility will require further evaluations in the
future.
Studies in rodents have suggested a number of tinnitus
neuronal correlates in the AC that translate into (i) an increase
in SFR, (ii) neuronal synchrony, (iii) tonotopic reorganization
(Elgoyhen et al., 2015; Shore et al., 2016). Such changes
could be the underlying cause of the inability of tinnitus-
experiencing rodents to have efficient startle suppression by
gaps. Weible et al. (2014) identified that comparisons between
pre- and post-gap neural activity determines the efficacy in
GPIAS. In the AC, parvalbumin-expressing and somatostatin-
expressing GABAergic interneurons exert their inhibitory activity
on CaMKII-expressing pyramidal neurons to regulate GPIAS
(Weible et al., 2014). Interestingly, the optogenetic inactivation
of inhibitory interneurons in the AC before or after the gap
enhances GPIAS, however, when this is performed throughout
pre-, during and post-gap, GPIAS could not be altered (Weible
et al., 2014). We thus believe that the continuous pharmacological
action of baclofen on the AC throughout the entire trial (pre-,
during and post-gap) could not restore GPIAS. This illustrates
the limitations of pharmacological approaches in testing the
mechanisms of gap detection when compared to the accuracy
of optogenetic approaches. We propose an initial model of
the regulation of PPI and GPIAS, where differences in the
modulation of the inhibitory path occur at the level of the
forebrain, in the LGP and the AU, respectively (Figure 5E).
A potential application of the present findings to humans
would be that, in the event such modulation of AC activity
would be detectable during GPIAS for instance by using
electroencephalography (EEG) or other non-invasive
neuroimaging techniques, such as positron emission tomography
(PET), we would predict responses to be altered in presence of
tinnitus. As the ASR in humans is highly variable (Braff et al.,
2001), and its reliability in presence of tinnitus questioned
(Fournier and Hebert, 2013), such measures could become
an interesting alternative to blinking responses. Since ABR
GIN responses closely reproduce behavioral startle responses
in presence of gaps (Lowe and Walton, 2015), a focus on
the AC response during gaps in noise appears as a feasible
path.
Whereas the role of the AC in GPIAS has been evidenced
here, it remains to be determined whether GPIAS has similar or
additional nuclei involved in the inhibitory pathway compared
to PPI. The neural pathways that control the inhibition of the
ASR by pre-pulses is established in higher order regions such
as the ventral hippocampus-medial prefrontal cortex (mPFC),
as well as the “CSPP” circuitry involving the limbic cortex,
striatum, pallidal or pontine tegmentum (Swerdlow et al., 2008,
2016). Acoustic pre-pulses are also regulated via the IC, superior
colliculus (SC), pedunculopontine tegmental nucleus (PPTg)
and substantia nigra pars compacta (Leitner and Cohen, 1985;
Koch et al., 1993; Li et al., 1998; Koch et al., 2000). The
large connectivity network involved in PPI emphasizes the need
of performing similar studies for GPIAS in order to better
understand the factors that modulate the inhibition by gaps and
how reliable this paradigm is in the context of assessment of
psychiatric and auditory processing disorders as well as tinnitus.
The recent findings that tinnitus is involving a large number of
non-auditory brain areas (Chen et al., 2015; Sedley et al., 2015)
predicts that other brain regions [e.g., amygdala, hippocampus,
cerebellum, medial geniculate body, and the reticular formation
(Eggermont, 2016)] may alter the efficacy of startle suppression
by gaps.
CONCLUSION
Gap pre-pulse inhibition of the acoustic startle and PPI both
rely on sound cues but utilize different neural pathways to
regulate the inhibition of the startle response. These different
sound cues, characterized by either an increase (pre-pulses)
or a decrease (gaps) in intensity, are recruiting different brain
regions. Pre-pulses are activating the LGP to inhibit the startle
response, while gaps bypass the LGP to activate the AC.
These results are establishing a neuroanatomical foundation for
understanding gap detection and its applicability in the context
of neurological disorders including auditory processing disorders
and tinnitus.
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